NCT07204314View on ClinicalTrials.gov

A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

September 30, 2029

Study Completion Date

September 30, 2029

Conditions

Major Depressive Disorder

Interventions

DRUG

Vortioxetine tablets

Vortioxetine tablets

DRUG

Placebo tablets

Placebo tablets

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY

NCT07204314 - A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter